Barry Hix is a proven commercial strategist with extensive experience in establishing adoption and market penetration for life science, medtech, and drug delivery products. Barry brings a unique lens developed through decades of working with healthcare's diverse ecosystem of stakeholders, patients, physicians, clinicians, payers, and key influencers. During the course of his 25 year career in healthcare, Hix has held executive leadership positions in both public and private companies in the pharmaceutical, healthcare delivery, medical device and healthcare technology industries.
Hix holds a Bachelor's degree in industrial management from the Georgia Institute of Technology, a Master's in marketing from Georgia State University and a Master's in public health from Emory University.
As Co-Founder and Chief Commercial Officer at Vector Science & Therapeutics, his proven ability to secure activation, adoption, and loyalty from critical healthcare stakeholder groups will be instrumental in the company's efforts to establish strong market positioning. His leadership at DJO Global resulted in the expansion of Empi's orthopedic and recovery-focused product portfolio into new medical condition targets for the company, including stroke.
Career history
- Chief Executive Officer at Vizbodx (2024–present)
- Co-Founder and Chief Commercial Officer at Vector Science & Therapeutics (2025–present)
- Advisor, Commercial Excellence, MedTech and Life Science at Six Bridges Advisors (2023–present)
- Managing Director at Hix Group, LLC (2010–2023)
- Chief Executive Officer at Cadence Biomedical (2014–2015)
What Barry Hix could bring to Vector Science & Therapeutics: As Co-Founder and Chief Commercial Officer, Hix's deep expertise in navigating healthcare's complex stakeholder ecosystem, combined with his track record at DJO Global expanding product portfolios into new clinical segments, positions him to accelerate adoption of Vector's novel biomechanical drug delivery platforms across clinician networks, payers, and patient populations as the company advances toward commercialization.
This is an automatically generated Light profile created by Executive Moves editorial systems from verified public announcements. Information is kept deliberately concise until the page is claimed and enriched.
Facts compiled by Executive Moves from publicly available news and press releases on 9 July 2026. Spotted an inaccuracy? Email us and we'll review within 1 business day.
To upgrade to a Premium Profile reach out to us at info@executive-moves.com.
Are you Barry Hix?
This is a Light profile, auto-generated from public news coverage. Claim it to verify your bio, add a photo and links, and control how your career is represented on Executive Moves.
Claim this profile →





